Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer

NCT00720083 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

NETWORK

Sponsor class

Stopped Withdrawal of drug supply.

Conditions

Head and Neck Cancer

Interventions

DRUG: cisplatin
DRUG: vandetanib
RADIATION: radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]